Bionano Genomics
BNGO
9 hedge funds and large institutions have $1.16M invested in Bionano Genomics in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0.03% → 0.03% (-0%)
10% less funds holding
Funds holding: 10 → 9 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
65% less capital invested
Capital invested by funds: $3.3M → $1.16M (-$2.13M)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$35.9K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$13.1K |
| 3 |
Morgan Stanley
New York
|
+$1.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$146K |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$41K |
| 3 |
Millennium Management
New York
|
-$22.9K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$14.2K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$13.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SCM
1
Sio Capital Management
New York
| $1M | -$146K | -134 | -5% |
|
|
MIM
2
Monashee Investment Management
Boston,
Massachusetts
| $59K | – | – | – |
|
|
WVP
3
Worth Venture Partners
Fort Lee,
New Jersey
| $58K | -$13.1K | -12 | -8% |
|
|
4
Millennium Management
New York
| $20K | -$22.9K | -21 | -30% |
|
|
VF
5
Virtu Financial
New York
| $14K | +$35.9K | +33 | New |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5K | +$13.1K | +12 | New |
|
7
BlackRock
New York
| $4K | – | – | – |
|
|
8
Victory Capital Management
San Antonio,
Texas
| $1K | -$14.2K | -13 | -93% |
|
|
9
Morgan Stanley
New York
| $1K | +$1.09K | +1 | +100% |
|
|
10
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$41K | -28 | Closed |
|
|
PAM
11
Panagora Asset Management
Boston,
Massachusetts
| – | -$11K | -7 | Closed |
|
12
Bank of America
Charlotte,
North Carolina
| – | -$1K | -1 | Closed |
|
13
UBS Group
Zurich,
Switzerland
| – | -$1K | – | – |
|
BNGO Hedge Fund Activity: Q3 2019 in Review
9 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2019, worth a combined $1.16M — down 65% from $3.3M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BNGO and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $35.9K. The largest seller was Sio Capital Management, cutting an estimated $146K.
- 9 institutional investors held Bionano Genomics (BNGO) as of Q3 2019, down from 10 in Q2 2019.
- Funds reported $1.16M of Bionano Genomics stock for Q3 2019, down 65% quarter-over-quarter.
- 2 funds opened new Bionano Genomics positions in Q3 2019 and 3 closed out, a net change of -1 holder.
- The largest Bionano Genomics buyer in Q3 2019 was Virtu Financial, an estimated $35.9K added.
- The largest Bionano Genomics seller in Q3 2019 was Sio Capital Management, an estimated $146K sold.
Based on aggregated 13F filings for Q3 2019.